BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21269507)

  • 21. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.
    Hegi ME; Diserens AC; Godard S; Dietrich PY; Regli L; Ostermann S; Otten P; Van Melle G; de Tribolet N; Stupp R
    Clin Cancer Res; 2004 Mar; 10(6):1871-4. PubMed ID: 15041700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications.
    Kang SH; Park KJ; Kim CY; Yu MO; Park CK; Park SH; Chung YG
    J Neurooncol; 2011 Feb; 101(3):477-86. PubMed ID: 20556478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
    Yamashita S; Yokogami K; Matsumoto F; Saito K; Mizuguchi A; Ohta H; Takeshima H
    J Neurosurg; 2018 May; 130(3):780-788. PubMed ID: 29726772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C; Ai L; Ratliff P; Suen JY; Hanna E; Brent TP; Fan CY
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):967-75. PubMed ID: 15184253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
    He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
    Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells.
    Kewitz S; Stiefel M; Kramm CM; Staege MS
    Leuk Res; 2014 Jan; 38(1):138-43. PubMed ID: 24284332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O6-methylguanine-DNA methyltransferase activity and promoter methylation status in pediatric rhabdomyosarcoma.
    Yeager ND; Dolan ME; Gastier JM; Gross TG; Delaney S; Frick J; Ruymann FB; Ewesuedo R
    J Pediatr Hematol Oncol; 2003 Dec; 25(12):941-7. PubMed ID: 14663276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
    Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
    Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas.
    Cao VT; Jung TY; Jung S; Jin SG; Moon KS; Kim IY; Kang SS; Park CS; Lee KH; Chae HJ
    Neurosurgery; 2009 Nov; 65(5):866-75; discussion 875. PubMed ID: 19834398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O
    Hiddinga BI; Pauwels P; Janssens A; van Meerbeeck JP
    Lung Cancer; 2017 May; 107():91-99. PubMed ID: 27492578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents.
    Walter T; van Brakel B; Vercherat C; Hervieu V; Forestier J; Chayvialle JA; Molin Y; Lombard-Bohas C; Joly MO; Scoazec JY
    Br J Cancer; 2015 Feb; 112(3):523-31. PubMed ID: 25584486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.
    Wu PF; Kuo KT; Kuo LT; Lin YT; Lee WC; Lu YS; Yang CH; Wu RM; Tu YK; Tasi JC; Tseng HM; Tseng SH; Cheng AL; Lin CH
    Lung Cancer; 2010 Jun; 68(3):484-90. PubMed ID: 19740564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of O-6-Methylguanine-DNA-Methyltransferase Promoter Methylation in Patients with Esophageal Carcinoma: A Systematic Meta-Analysis.
    Zhang Y; Tong T
    Dig Dis; 2018; 36(2):89-97. PubMed ID: 29258097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [O6-methylguanine-DNA-methyltransferase (MGMT) expression in patients with glioblastoma multiforme].
    Jiménez D; Matamala JM; Chiti A; Vergara C; Tissera C; Melo R; Cartier L
    Rev Med Chil; 2018 Jan; 146(1):7-14. PubMed ID: 29806672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.
    Park CK; Kim J; Yim SY; Lee AR; Han JH; Kim CY; Park SH; Kim TM; Lee SH; Choi SH; Kim SK; Kim DG; Jung HW
    Neuro Oncol; 2011 Feb; 13(2):195-202. PubMed ID: 21075779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene.
    Nakamura M; Watanabe T; Yonekawa Y; Kleihues P; Ohgaki H
    Carcinogenesis; 2001 Oct; 22(10):1715-9. PubMed ID: 11577014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O
    Alassiri AH; Alkhaibary A; Al-Sarheed S; Alsufani F; Alharbi M; Alkhani A; Aloraidi A
    Ann Saudi Med; 2019; 39(6):410-416. PubMed ID: 31804140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
    Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS
    Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.